These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11015698)

  • 1. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
    Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
    Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
    Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
    Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.
    Brajenović-Milić B; Prpić I; Petrović O; Ristić S; Brumini G; Kapović M
    Matern Child Health J; 2008 Sep; 12(5):620-3. PubMed ID: 17712614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
    de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
    J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.
    van Gameren-Oosterom HB; Buitendijk SE; Bilardo CM; van der Pal-de Bruin KM; Van Wouwe JP; Mohangoo AD
    Prenat Diagn; 2012 Nov; 32(11):1035-40. PubMed ID: 22865545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
    Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013.
    Maxwell S; Bower C; O'Leary P
    Prenat Diagn; 2015 Dec; 35(13):1324-30. PubMed ID: 26411476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992.
    Olsen CL; Cross PK; Gensburg LJ; Hughes JP
    Prenat Diagn; 1996 Nov; 16(11):991-1002. PubMed ID: 8953632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of prevalence of Down syndrome in Southern Thailand.
    Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
    World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
    de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
    Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait.
    Olsen CL; Cross PK; Gensburg LJ
    Hum Biol; 2003 Aug; 75(4):503-20. PubMed ID: 14655874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of maternal age distribution on the expected live birth prevalence of Down's syndrome in the metropolitan France between 1965 and 2008].
    Rousseau T; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):284-9. PubMed ID: 20381272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.
    Deng C; Yi L; Mu Y; Zhu J; Qin Y; Fan X; Wang Y; Li Q; Dai L
    Prenat Diagn; 2015 Apr; 35(4):311-8. PubMed ID: 25315427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antenatal screening for Down syndrome in Western Australia: 1980-1994.
    O'Leary P; Bower C; Murch A; Crowhurst J; Goldblatt J
    Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):385-8. PubMed ID: 9006817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in The Netherlands.
    de Graaf G; Haveman M; Hochstenbach R; Engelen J; Gerssen-Schoorl K; Poddighe P; Smeets D; van Hove G
    J Intellect Disabil Res; 2011 May; 55(5):462-73. PubMed ID: 21375641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome prevention program in a population with an older maternal age.
    Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.
    de Groot-van der Mooren MD; Tamminga S; Oepkes D; Weijerman ME; Cornel MC
    Eur J Hum Genet; 2018 Feb; 26(2):157-165. PubMed ID: 29330546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal testing for Down syndrome in the Jewish and non-Jewish populations in Israel.
    Davidov B; Goldman B; Akstein E; Barkai G; Legum C; Dar H; Romem Y; Amiel A; Cohen H; Bach G
    Isr J Med Sci; 1994 Aug; 30(8):629-33. PubMed ID: 8045747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.